Cancer begins with errors in the DNA inside our cells, and those errors are often more complicated than a handful of mutated ...
• Applications of germline genetic testing, tumor genomics, and other biomarkers are now routinely used in risk assessment, determination of treatment course, prognosis, and monitoring. • Imaging ...